Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

QTNT
Quotient Limited
stock NASDAQ

Inactive
Dec 30, 2022
0.3800USD+2.730%(+0.0101)5,811,488
Pre-market
0.00USD-100.000%(-0.37)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
04:30PM EST  Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2021 will be released before market open on Tuesday, February 8, 2022.   GlobeNewswire Inc
Jan 26, 2022
08:30AM EST  Quotient Limited Launches Scientific Advisory Board and Research   GlobeNewswire Inc
Dec 15, 2021
08:34AM EST  UPDATE: Quotient Sees Approval For MosaiQ In Q1'22   Benzinga
08:34AM EST  Quotient Offers Update On MosaiQ Exapnded Immunohematology Microarray CE Marking Progress: Received Feedback From European Notified Body, Was Pleased With Feedback, Sees Response Submission In 'Next Couple Weeks'   Benzinga
08:30AM EST  -- Received feedback from the European notified body after review of Expanded IH submission -- Pleased with feedback and expect to submit a response to the questions in the next couple of weeks -- Continue to expect approval in Q1 CY 2022   GlobeNewswire Inc
Dec 3, 2021
01:16PM EST  Quotient Wins $77M Defense Logistics Agency Contract   Benzinga
09:09AM EST  Goldman Sachs Maintains Neutral on Quotient, Lowers Price Target to $3.5   Benzinga
Nov 30, 2021
08:30AM EST  Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Mr. Esteban Uriarte as the Companys Chief Manufacturing Operations Officer (CMOO). Mr. Uriarte will assume the responsibilities of CMOO on February 1st, 2022.   GlobeNewswire Inc
Nov 19, 2021
08:21AM EST  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to Mr. Ali Kiboro, who has been appointed as the Chief Financial Officer of the Company effective November 1, 2021.   GlobeNewswire Inc
Nov 12, 2021
04:15PM EST  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the management team will present at the Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at 8:40am GMT (3:40am ET).   GlobeNewswire Inc
Nov 9, 2021
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
11:07AM EST  Quotient Sees Q2 Year-Over-Year Growth In Alba Platform 15.9%, Unaudited Sales Exceeded Previously-Issued Guidance   Benzinga
11:07AM EST  Quotient Reaffirms FY22 Guidance   Benzinga
11:07AM EST  Quotient Delays Its Q2'22 Results As Is 'working through a technical, non-cash accounting adjustment related to the historical treatment of debt and associated royalty rights contracts'   Benzinga
Nov 8, 2021
04:05PM EST  Quotient Limited Provides Business Update and Delays Releasing   GlobeNewswire Inc
Oct 26, 2021
08:00AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that financial results for its fiscal second quarter ended September 30, 2021 will be released before market open on Tuesday,November 9, 2021.   GlobeNewswire Inc
Oct 14, 2021
08:45AM EDT  -- Notes holders unanimously consent to amendments -- Companys near-term cash obligations reduced by approximately $60 million -- Transaction extends liquidity runway through commercial launch and provides resources for further MosaiQ investment   GlobeNewswire Inc
Oct 12, 2021
08:46AM EDT  Quotient Names Ali Kiboro CFO   Benzinga
08:45AM EDT  Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Companys Chief Financial Officer (CFO). Mr. Kiboro will assume the responsibilities of CFO on November 1st, 2021, replacing Mr. Peter Buhler who will support the Company during the transitional phase, as needed, before leaving Quotient Limited at year-end.   GlobeNewswire Inc
Oct 5, 2021
07:45AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced Mohammad El Khoury as the Companys Chief Commercial Officer. In this role, Mr. El Khoury will oversee all commercial activities for the company as it continues to expand globally.   GlobeNewswire Inc
Oct 4, 2021
08:48AM EDT  Quotient Limited Appoints Dr. Christine Ginocchio As Chief Scientific & Medical Officer   Benzinga
08:41AM EDT  Quotient Appoints Christine Ginocchio As Chief Scientific & Medical Officer   RTTNews
08:30AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Dr. Christine Ginocchio as Chief Scientific & Medical Officer (CSMO).   GlobeNewswire Inc
Oct 1, 2021
06:02AM EDT  Quotient Reports Commencement Of Review Process Of Expanded Immunohematology Technical File Dossier By European Notified Body   Benzinga
06:00AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the launch of the review process of the Expanded Immunohematology (IH) technical file dossier for review by the European notified body. The Company submitted part I of the dossier in September as planned.   GlobeNewswire Inc
Sep 17, 2021
03:38PM EDT  Quotient Wins $3.7M Veterans Affairs Contract   Benzinga
Sep 1, 2021
08:22AM EDT  Quotient Limited(NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that Christian Albrich has been appointed as Chief People Officer of the Company and will begin serving in that role as of today.   GlobeNewswire Inc
Aug 11, 2021
07:45AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Jeremy Stackawitz has notified the Company that he is resigning from his position as Chief Commercial Officer.   GlobeNewswire Inc
Aug 6, 2021
08:51AM EDT  Goldman Sachs Maintains Neutral on Quotient, Lowers Price Target to $4.5   Benzinga
Aug 5, 2021
06:35AM EDT  Quotient Sees FY22 Alba Sales $35.5M-$36.5M   Benzinga
06:35AM EDT  Quotient Q1 EPS $(0.24) Beats $(0.27) Estimate, Sales $9.09M Miss $9.27M Estimate   Benzinga
06:30AM EDT  Quotient Limited Provides First Quarter Fiscal 2022 Results and   GlobeNewswire Inc
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Aug 2, 2021
04:30PM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the grant of equity awards to Dr. Michael Hausmann, who has been appointed as the Chief Technology Officer of the Company effective August 1, 2021.   GlobeNewswire Inc
Jul 29, 2021
08:30AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2021 will be released before market open on Thursday, August 5, 2021.   GlobeNewswire Inc
Jul 7, 2021
11:14AM EDT  Quotient Insights: Return On Capital Employed   Benzinga
Jul 2, 2021
04:30PM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), announced that Peter Buhler has notified the Company that he is resigning from his position as Chief Financial Officer to take a position with another company.   GlobeNewswire Inc
04:16PM EDT  Quotient Says In 8K Filing Chief Financial Officer, Peter Buhler, Has Notified Co. Of Resignation; Co. Says Has Initiated Search For Replacement, Expects To Have New CFO In Place Before Dec. 31, 2021, Effective Date Of Buhler's Resignation   Benzinga
Jun 3, 2021
10:09AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021   Benzinga
06:31AM EDT  Goldman Sachs Initiates Coverage On Quotient with Neutral Rating, Announces Price Target of $5   Benzinga
Jun 2, 2021
07:48AM EDT  Quotient's Debt Insights   Benzinga
Jun 1, 2021
07:07AM EDT  Recap: Quotient Q4 Earnings   Benzinga
06:34AM EDT  Quotient Sees FY22 Total Sales Of Alba $35.5M-$36.5M   Benzinga
06:34AM EDT  Quotient Q4 Sales $9.64M Beat $8.80M Estimate   Benzinga
06:30AM EDT  Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021   GlobeNewswire Inc
04:20AM EDT  Earnings Scheduled For June 1, 2021   Benzinga
May 31, 2021
08:00AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the management team will participate in two upcoming investor conferences.   GlobeNewswire Inc
May 25, 2021
08:30AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2021 will be released before market open on Tuesday, June 1, 2021.   GlobeNewswire Inc
May 24, 2021
08:08AM EDT  Quotient Limited Announces New $95M Financing Led by Highbridge   Benzinga
08:00AM EDT  -- Transaction proceeds will be used to fund the further development of the MosaiQ platform beyond the Donor Lab and the commercial launch of MosaiQ   GlobeNewswire Inc
Apr 12, 2021
09:00AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the company has been recognized with a 2021 Red Dot Product Design Award for the full MosaiQ by Quotient system.   GlobeNewswire Inc
Apr 5, 2021
04:05PM EDT  Quotient Reports Result From Study Of Its MosaiQ Multiplex Molecular Disease Screening Microarray   Benzinga
04:05PM EDT  Quotient Limited Reports Further Enhanced Multimodal Capabilities   GlobeNewswire Inc
Mar 1, 2021
08:00AM EST  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to Mr. Manuel Mendez, who has been appointed as the Chief Executive Officer of the Company effective April 1, 2021.   GlobeNewswire Inc
Feb 24, 2021
04:05PM EST  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the Company will present at the Cowen 41st Annual Healthcare Conference on Monday, March 1, 2021 at 1:20pm ET.   GlobeNewswire Inc
Feb 23, 2021
06:23AM EST  Quotient Limited Appoints Manuel Mendez As Chief Executive Officer   Benzinga
06:23AM EST  Quotient Limited Announces Manuel Mendez As CEO And Will Begin Serving In That Role On April 1, 2021   RTTNews
06:20AM EST  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that Manuel Mendez has been appointed as Chief Executive Officer of the Company and will begin serving in that role on April 1st, 2021. Franz Walt, who has served as the companys CEO since 2018 is retiring.   GlobeNewswire Inc
Feb 12, 2021
09:00AM EST  Quotient Limited(NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced the Company will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Thursday, February 18.   GlobeNewswire Inc
Feb 1, 2021
09:54AM EST  Stock Alert: Quotient Down 12%   RTTNews
07:21AM EST  Recap: Quotient Q3 Earnings   Benzinga
06:06AM EST  Quotient Q3 EPS $(0.29), Inline, Sales $8.75M Beat $8.30M Estimate   Benzinga
06:00AM EST  -- MosaiQ COVID-19 semi-quantitative antibody test CE marked -- Expanded MosaiQ IH microarray EU launch planned for fourth quarter CY2021 -- Sales of Alba by Quotient reagents exceed guidance -- Strong cash position in place to carry us into commercialization   GlobeNewswire Inc
04:00AM EST  Earnings Scheduled For February 1, 2021   Benzinga
Jan 29, 2021
10:11AM EST  Quotient Earnings Preview   Benzinga
Jan 19, 2021
08:00AM EST  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2020 will be released before market open on Monday, February 1, 2021.   GlobeNewswire Inc
Jan 12, 2021
09:10AM EST  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced it has been named a winner in the prestigious 2021 BIG Innovation Awards presented by the Business Intelligence Group. The annual awards program recognizes the organizations, products and people that bring new ideas to life.   GlobeNewswire Inc
Dec 22, 2020
04:05PM EST  Quotient Reports COO Ed Farrell To Resign; Co. Says Will Not Seek To Replace Role   Benzinga
04:05PM EST  Quotient Limited Announces Departure of Chief Operating Officer   GlobeNewswire Inc
Dec 10, 2020
08:38AM EST  Quotient Limited Receives Request From FDA For Additional Testing Data Regarding 510(k) Application For SDS And MosaiQ Instrument; Intends To Re-Submit Its Application With Additional Data In Early 2021   Benzinga
08:30AM EST  Quotient Limited Provides Status Update on the Initial SDS   GlobeNewswire Inc
Nov 30, 2020
04:05PM EST  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported preliminary EU field trial performance data for its MosaiQ Expanded Immunohematology (IH) Microarray. The data suggest that tests performed with Quotient's Microarray are highly accurate.   GlobeNewswire Inc
Nov 9, 2020
04:05PM EST  Quotient Limited(NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that the Company will participate in two upcoming virtual investor conferences.   GlobeNewswire Inc
Nov 5, 2020
04:45PM EST  Quotient Sees FY 2021 Alba Sales Between $32M And $34M   Benzinga
04:44PM EST  Quotient Q2 EPS $(0.18) Beats $(0.33) Estimate, Sales $16.07M Beat $7.90M Estimate   Benzinga
Nov 2, 2020
08:27AM EST  Recap: Quotient Q2 Earnings   Benzinga
07:55AM EST  Earnings Scheduled For November 2, 2020   Benzinga
06:06AM EST  Quotient Q2 EPS $(0.18) Beats $(0.33) Estimate, Sales $16.07M Beat $7.90M Estimate   Benzinga
06:00AM EST  Quotient Limited Reports Second Quarter Fiscal 2021 Results and   GlobeNewswire Inc
Oct 30, 2020
04:30PM EDT  Notable Earnings Watchlist For Monday, Nov. 2, 2020 Before Market Open: NI, TEN, WM, MPLX, CWH, CLX, AMCX, INGR, MPC, JLL, LCII, CDW, HSIC, EL, QTNT, CNA, ON, LITE   Benzinga
Oct 19, 2020
08:48AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter ended September 30, 2020 will be released before market open on Monday, Nov 2, 2020.   GlobeNewswire Inc
Sep 28, 2020
07:31AM EDT  Diagnostics company Quotient Ltd. (QTNT) announced Monday that the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) on Friday for its COVID-19 antibody test. Before granting the EUA, the FDA reviewed not only its COVID-19 antibody test but also the MosaiQ Instrument and related software.   RTTNews
07:11AM EDT  Quotient Gets FDA Emergency Use Authorization For MosaiQ COVID-19 Antibody Test   RTTNews
07:00AM EDT  Quotient Limited Announces Receipt of U.S. FDA Emergency Use   GlobeNewswire Inc
Sep 20, 2020
10:09AM EDT  Notable Insider Buys of the Past Week: Nikola, Transdigm And More   Benzinga
Sep 16, 2020
11:07AM EDT  Insider Buys Quotient's Stock   Benzinga
Sep 15, 2020
04:05PM EDT  Quotient Limited Announces Closing of Underwritten Offering of   GlobeNewswire Inc
Sep 10, 2020
08:42PM EDT  Quotient Limited Announces Upsize and Pricing of Underwritten   GlobeNewswire Inc
Sep 9, 2020
04:07PM EDT  Quotient Limited Announces A $60M Common Stock Offering   Benzinga
04:05PM EDT  Quotient Limited Announces Proposed Underwritten Offering of   GlobeNewswire Inc
Sep 8, 2020
06:17AM EDT  Quotient Limited And Ortho Clinical Diagnostics Settle Arbitration And Sign Binding Letter Of Intent Covering Patient Transfusion Diagnostics; Under Agreement, Quotient Entitled To Payments Of Up To $67.5M   Benzinga
06:15AM EDT  Quotient Limited and Ortho Clinical Diagnostics Settle Arbitration   GlobeNewswire Inc
Aug 27, 2020
08:30AM EDT  -- Testing Conducted Using the Highly Accurate MosaiQ COVID-19 Antibody Test from Quotient   GlobeNewswire Inc
Aug 21, 2020
04:19PM EDT  Quotient Ltd Files Mixed Shelf Of Up To $200M   Benzinga
Aug 4, 2020
09:15AM EDT  Quotient Limited(NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the earnings call for fiscal quarter ended June 30, 2020.   GlobeNewswire Inc
Aug 3, 2020
02:35PM EDT  Mid-Afternoon Market Update: Dow Surges 260 Points; Varian Medical Systems Shares Climb   Benzinga
07:49AM EDT  Quotient: Q1 Earnings Insights   Benzinga
06:21AM EDT  Quotient Sees FY2021 Sales $32.000M-34.000M vs $36.00M Est   Benzinga
06:15AM EDT  Quotient Q1 EPS $(0.32) Beats $(0.33) Estimate, Sales $8.92M Beat $8.67M Estimate   Benzinga
06:00AM EDT  -- Significant progress in three targeted areas of MosaiQ development COVID-19 antibody test, potential new applications, and transfusion diagnostics -- Ten commercial placements of MosaiQ platform in Europe and the US -- Continued YoY Strong Top Line Growth for Alba by Quotient reagents -- Added to Russell 2000 and 3000 Indexes   GlobeNewswire Inc
04:13AM EDT  Earnings Scheduled For August 3, 2020   Benzinga
Jul 23, 2020
08:30AM EDT  Quotient Limited(NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced that Dr. Isabelle Buckle, Ph.D. and Dr. Catherine Larue, Ph.D. will join the Companys Board of Directors, effective September 1, 2020.   GlobeNewswire Inc
08:29AM EDT  Quotient Adds New Board Members, Isabelle Buckle And Catherine Larue   RTTNews
08:15AM EDT  Quotient Limited(NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced changes in the composition of its board of directors that will take effect later this year. Two of the Company's directors will be leaving the board and, effective September 1, 2020, two new directors will be joining.   GlobeNewswire Inc
Jul 20, 2020
03:11PM EDT  Quotient shares are trading higher after the company reported impressive results from its independent SARS-CoV-2 antibody detection study.   Benzinga
06:35AM EDT  Quotient Limited Reports Impressive Results from an Independent SARS-CoV-2 Antibody Detection Study Conducted in Spain   Benzinga
06:24AM EDT  Quotient Ltd. (QTNT) reported that an independent study conducted in Madrid, Spain has confirmed the high performance characteristics of the company's MosaiQ COVID-19 Antibody Microarray. The study was conducted at an independent laboratory using over 500 samples.   RTTNews
06:15AM EDT  Quotient Says Impressive Results From SARS-CoV-2 Antibody Detection Study Conducted In Spain   RTTNews
06:00AM EDT  Quotient Limited Reports Impressive Results from an Independent   GlobeNewswire Inc
Jul 17, 2020
08:00AM EDT  Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2020 will be released before market open on Monday, August 3, 2020.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC